Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids plus hydroxychloroquine versus corticosteroids in first-line treatment of ANA-positive primary immune thrombocytopenia
ChiCTR2100045747Phase 4Recruiting
- Sponsor
- Fudan University Jinshan Hospital
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in immune thrombocytopenia (ITP) comparing hydroxychloroquine + dexamethasone with Control: dexamethasone (2 arms). Primary endpoints: response rate and response duration. Started Dec 2020; status: recruiting.
02
Drugs
hydroxychloroquinedexamethasone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR2100045747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045747.